ArticleHealth research policy and systems2006
Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence.
Article in Health research policy and systems, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 117 citations in OpenAlex.
- Quality assessment tools used in systematic reviews of in vitro studies: A systematic review.BMC medical research methodology · 2021Pooled it
- Quality of reviews on sugar-sweetened beverages and health outcomes: a systematic review.The American journal of clinical nutrition · 2011Pooled it
- Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review.BMC medical informatics and decision making · 2008Pooled it
- Effects of an evidence service on health-system policy makers' use of research evidence: a protocol for a randomised controlled trial.Implementation science : IS · 2011Trial
- Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study.Drug safety · 2025Article
- Guidance for engagement in health guideline development: A scoping review.Campbell systematic reviews · 2024Article
- Validity of data extraction in acupuncture meta-analysis: a reproducibility study protocol.BMJ open · 2024Article
- Article
- PROTOCOL: Guidance for stakeholder engagement in guideline development: A systematic review.Campbell systematic reviews · 2022Article
- Usefulness of Cochrane Reviews in Clinical Guideline Development-A Survey of 585 Recommendations.International journal of environmental research and public health · 2022Article
- Overview of the Effect of Complementary Medicine on Treating or Mitigating the Risk of Endometriosis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2021Review
- Evaluating the Quality of Systematic Reviews and Meta-Analyses About Breast Augmentation Using AMSTAR.Aesthetic surgery journal. Open forum · 2021Article
- A Semiautomated Classification System for Producing Service Directories in Social and Health Care (DESDE-AND): Maturity Assessment Study.Journal of medical Internet research · 2021Article
- Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?Military Medical Research · 2020Review
- Evaluation of an HIV-specific rapid response service for community-based organisations in Ontario, Canada.Health research policy and systems · 2019Article
- Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 - Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements.Health research policy and systems · 2019Article
- Effect of Isoflavones and Genistein on Glucose Metabolism in Peri- and Post-Menopausal Women: An Overview of Meta-Analysis.Journal of menopausal medicine · 2019Review
- Overview of the Effect of Herbal Medicines and Isoflavones on the Treatment of Cognitive Function.Journal of menopausal medicine · 2018Article
- An analysis of methods used to synthesize evidence and grade recommendations in food-based dietary guidelines.Nutrition reviews · 2018Review
- Fit for purpose: perspectives on rapid reviews from end-user interviews.Systematic reviews · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization (WHO), like many other organisations around the world, has recognised the need to use more rigorous processes to ensure that health care recommendations are informed by the best available research evidence. This is the eighth of a series of 16 reviews that have been prepared as background for advice from the WHO Advisory Committee on Health Research to WHO on how to achieve this.
objectivesWe reviewed the literature on the synthesis and presentation of research evidence, focusing on four key questions.
methodsWe searched PubMed and three databases of methodological studies for existing systematic reviews and relevant methodological research. We did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence, consideration of what WHO and other organisations are doing and logical arguments. KEY QUESTIONS AND ANSWERS: We found two reviews of instruments for critically appraising systematic reviews, several studies of the importance of using extensive searches for reviews and determining when it is important to update reviews, and consensus statements about the reporting of reviews that informed our answers to the following questions. How should existing systematic reviews be critically appraised? Because preparing systematic reviews can take over a year and require capacity and resources, existing reviews should be used when possible and updated, if needed. Standard criteria, such as A MeaSurement Tool to Assess Reviews (AMSTAR), should be used to critically appraise existing systematic reviews, together with an assessment of the relevance of the review to the questions being asked. When and how should WHO undertake or commission new reviews? Consideration should be given to undertaking or commissioning a new review whenever a relevant, up-to-date review of good quality is not available. When time or resources are limited it may be necessary to undertake rapid assessments. The methods that are used to do these assessments should be reported, including important limitations and uncertainties and explicit consideration of the need and urgency of undertaking a full systematic review. Because WHO has limited capacity for undertaking systematic reviews, reviews will often need to be commissioned when a new review is needed. Consideration should be given to establishing collaborating centres to undertake or support this work, similar to what some national organisations have done. How should the findings of systematic reviews be summarised and presented to committees responsible for making recommendations? Concise summaries (evidence tables) of the best available evidence for each important outcome, including benefits, harms and costs, should be presented to the groups responsible for making recommendations. These should include an assessment of the quality of the evidence and a summary of the findings for each outcome. The full systematic reviews, on which the summaries are based, should also be available to both those making recommendations and users of the recommendations. What additional information is needed to inform recommendations and how should this information be synthesised with information about effects and presented to committees? Additional information that is needed to inform recommendations includes factors that might modify the expected effects, need (prevalence, baseline risk or status), values (the relative importance of key outcomes), costs and the availability of resources. Any assumptions that are made about values or other factors that may vary from setting to setting should be made explicit. For global guidelines that are intended to inform decisions in different settings, consideration should be given to using a template to assist the synthesis of information specific to a setting with the global evidence of the effects of the relevant interventions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.